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| INTRODUCTION
The intestinal epithelium is constantly renewed and repaired throughout life by the action of multipotent stem cells that give rise to a population of proliferative and undifferentiated cells. These progenitor cells, also called transit-amplifying (T/A) cells, proliferate rapidly while migrating along the crypt axis. In the small intestine, the progenitor cells cease their proliferation after two to three divisions and differentiate in absorptive enterocytes, mucus-producing goblet cells, hormone-secreting enteroendocrine cells, or Paneth cells.
While the first three cell types differentiate during an upward migration from the crypt to the adjacent villus, Paneth cells differentiate during a downward movement to the crypt base. In contrast to the small intestine, the colonic epithelium displays epithelial caps instead of villi and deeper crypts devoid of Paneth cells (Barker, 2014; Crosnier, Stamataki, & Lewis, 2006) .
A central role for wingless (Wnt), bone morphogenetic proteins/ transforming growth factor β (TGFβ), Notch, and epidermal growth factor (EGF) signal transduction pathways in the maintenance, proliferation, and differentiation of intestinal stem and progenitor cells has been demonstrated in several murine models (Andreu et al., 2005; Carragher et al., 2010; van Es et al., 2005Feng et al., 2011 Fre et al., 2005; Haigis et al., 2008; Haramis et al., 2004; He et al., 2004; Janssen et al., 2002; Jensen et al., 2000; Korinek et al., 1998; Kuhnert et al., 2004; Milano et al., 2004; Pinto, Gregorieff, Begthel, & Clevers, 2003; Sansom et al., 2004; Yang, Bermingham, Finegold, & Zoghbi, 2001; Zecchini, Domaschenz, Winton, & Jones, 2005) . EGF and its orthologs epiregulin and TGFα, control epithelial cell proliferation by activating the Ras/Raf/ MEK/ERK (extracellular signal-regulated kinase) mitogen-activated protein kinase pathway (MAPK) and phosphatidylinositol 3-kinase (PI3K)/ Akt signaling pathways (Riese & Cullum, 2014; Wee & Wang, 2017) .
More specifically, we and others have observed a close correlation between the activation of MAPK/Erk kinase (MEK)/ERK signaling and proliferation on cultured intestinal epithelial cells (IEC; Aliaga, Deschênes, Beaulieu, Calvo, & Rivard, 1999; Boucher, Jean, Vézina, & Rivard, 2004; Dionne et al., 1998; Paquin, Cagnol, Carrier, Leblanc, & Rivard, 2013; Rhoads et al., 1997; Rivard, Boucher, Asselin, & L'Allemain, 1999; Sheng, Bernabe, Guo, & Warner, 2006) . Indeed, pharmacological inhibition of MEK activity blocks IEC cell cycle progression in G1 phase (Aliaga et al., 1999; Balmanno, Chell, Gillings, Hayat, & Cook, 2009; Paquin et al., 2013; Rivard et al., 1999) . Accordingly, high ERK activity is detected in progenitor cells of the crypt T/A zone in human intestinal epithelium where ERK1/2 may direct the proliferation to differentiation switch (Aliaga et al., 1999) . Indeed, we and others have reported that ERK1/2 are selectively inactivated during absorptive cell differentiation (Aliaga et al., 1999; Ding, Wang, & Evers, 2001; Lemieux et al., 2011; Taupin & Podolsky, 1999) . These data support the hypothesis that ERK1/2 kinase activity must be shut down to initiate the differentiation process in the intestine, at least in enterocytes.
ERK1/2 activation depends on phosphorylation of threonine and tyrosine amino acids in a specific TEY motif. Dephosphorylation of these residues by specific dual-specificity phosphatases (DUSP), also known as mitogen-activated protein kinase phosphatases (MKP), mediates the end of the signal. There are two groups of ERK1/2-targeting DUSP depending on their subcellular localization, namely, DUSP1/MKP-1, DUSP2/PAC-1, DUSP4/MKP-2, and DUSP5 localized in the nucleus, or DUSP6/MKP-3, DUSP7/MKP-X, and DUSP9/MKP-4 localized in the cytoplasm (Kidger & Keyse, 2016; Owens & Keyse, 2007) . DUSPs are characterized by their variable N-terminal MAPK-binding region including the kinase interaction motif (KIM) that governs substrate specificity and stability of interaction (Owens & Keyse, 2007; Tanoue, Adachi, Moriguchi, & Nishida, 2000) . Very few studies have analyzed the expression or function of these enzymes in the intestine. Interestingly, the elevated DUSP1 expression is detected in differentiated villus cells but not in proliferating crypt cells in the adult intestine (Noguchi et al., 1993) . In the mouse intestine, Dusp6 is predominantly detected in the differentiated epithelium (Ruan et al., 2016) . In line with these results, expression of both DUSP1 and DUSP6 markedly increases during enterocyte differentiation of human Caco-2/15 cells, hence correlating with dramatic inhibition of ERK1/2 activities (Aliaga et al., 1999; Taupin & Podolsky, 1999) . These observations suggest that ERK activity is tightly controlled by DUSP, both in its duration and intensity, during IEC differentiation.
In the current study, we have focused on the role of DUSP6, the first MKP to be characterized with absolute substrate specificity for ERK as opposed to either JNK or p38 (Groom, Sneddon, Alessi, Dowd, & Keyse, 1996; Muda et al., 1996) . More specifically, this phosphatase recognizes and binds the biphosphorylated ERK (pT183pY185) via its conserved KIM domain. Binding to ERK1/2 allosterically increases the catalytic activity of DUSP6 which then dephosphorylates ERK1/2 (Camps et al., 1998) .
To determine the role of DUSP6 in intestinal homeostasis, we have analyzed the intestinal epithelial phenotype of Dusp6 knockout (KO) mice under normal, oncogenic, and proinflammatory conditions. Our results demonstrate that DUSP6, by controlling ERK1/2 activation, regulates colonic inflammatory responses and protects the intestinal epithelium against oncogenic stress.
| MATERIALS AND METHODS

| Antibodies and reagents
Primary antibodies were obtained from the following sources: DUSP6 MA) and polyp numbers were counted from the duodenum to the rectum as previously described (Perreault, Sackett, Katz, Furth, & Kaestner, 2005) . Tissues were fixed, paraffin embedded, sectioned, and stained as described before (Leblanc et al., 2017) . Immunohistochemistry staining was performed with the Dako EnVision+System Kit (Dako, Santa Clara, CA) according to the manufacturer's recommendations. Immunofluorescence against chromogranin A was performed as described previously (C.
| Animals
S. Lee, Perreault, Brestelli, & Kaestner, 2002 
| Dextran sulfate sodium (DSS) treatment
Eleven-week-old mice were administered 2% DSS (36-50 kDa; MP Biomedicals) in drinking water ad libitum for 7 days. Disease activity index (DAI) was measured at sacrifice according to Cooper, Murthy, Shah, and Sedergran (1993) criteria: stool consistency (0-4), rectal bleeding (0-4), colon hardening (0-4), and occult bleeding (0-4).
Histological score was based on the presence or absence of mucosal architecture destruction, immune cell infiltration, muscle thickening, Goblet cell depletion, and crypt abscesses, as previously described (Coulombe et al., 2016 ). For all experiments, at least three different cell populations originating from three different infections were analyzed.
| Cell culture
| Soft agarose and invasion assays
Soft agarose assays were performed with 30,000 cells per well for HT29 cells and 15,000 cells per well for HCT116 cells as previously described (Bian et al., 2016) . After 14 days, colonies were stained with MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) for 5 hr at 37°C.
Images were acquired using an Infinity VX2 1100/26MX Imaging System (Vilber Lourmat, Marne-la-Vallée, France) and colonies were counted with the Image J software (NIH 
| Human colorectal tissues
Samples from colorectal tumors and paired normal tissues, at least 10 cm from a tumor, were resected, processed, classified, and graded from patients who did not receive neoadjuvant therapy as previously described (Bian et al., 2016) . 
| Western blot analysis
Proteins were isolated from scraped colonic mucosa enrichments of 12-week-old mice in chilled radioimmunoprecipitation assay buffer. For HT29 and HCT116 cell cultures, protein samples were prepared in Laemmli buffer as previously described (Bian et al., 2016) . Western blot analyses were performed as described previously (Bian et al., 2016 (Maillet et al., 2008) . was not significantly modulated in Dusp6-deficient colons, as determined by qPCR analysis (Figure 1d ).
To assess the intrinsic effect of Dusp6 deficiency on intestinal epithelial cell regeneration, we used a crypt colonoid culture system.
As shown in Figure 2a , loss of Dusp6 significantly promoted colonic organoid development. Indeed, Dusp6 -/-colonoid sizes were larger after 7 and 9 days in culture compared to control colonoids ( Figure 2b ). Furthermore, Dusp6-deficient colonoid proliferation was increased in comparison to wild-type colonoids, as determined by EdU incorporation (Figure 2c ). These data indicate that Dusp6 deletion leads to increased IEC proliferation.
| Dusp6 deletion induces goblet cell expansion without affecting enteroendocrine and absorptive cell differentiation
We next verified whether loss of Dusp6 modulates IEC differentiation in the colon. Dusp6 deletion did not alter enteroendocrine cell differentiation. Indeed, the number of chromogranin-positive cells was not increased in mutant mouse colons in comparison to control mice, as assessed by immunofluorescence (Figure 3a) . Additionally, expression of the enteroendocrine cell marker Neurogenin-3 was not significantly modified without Dusp6 (Figure 3b ). Dusp6 deletion also did not alter absorptive cell differentiation as both control and mutant mouse colons exhibited similar expression level of the absorptive cell marker Slc26a3, as determined by qPCR (Figure 3b ).
Hence, Dusp6 deletion does not affect enteroendocrine and absorptive cell differentiation.
In contrast, the number of goblet cells was significantly increased in Dusp6 −/− mouse colons in comparison to controls, as determined F I G U R E 1 Dusp6 deletion promotes colonic epithelial cell proliferation. (a) ERK1/2 phosphorylation and Dusp6 expression were analyzed by western blot on colonic mucosal enrichments from 12-week-old Dusp6 knockout and control mice (n = 5). β-Actin and ERK1/2 expression served as loading controls. Representative immunoblots are shown. (b) Colon tissue architecture was visualized with H&E staining and crypt depth was measured (n = 11). Scale bars=100 µm. (c) Immunohistochemistry against Ki67 was performed to measure proliferation. The number of positive cells per crypt was counted (n = 12). Scale bars=50 µm. (d) Relative Ascl2 and Lgr5 mRNA expression were quantified by qPCR with RNAs isolated from 12-week-old murine total colonic extracts (n = 11). Relative expression was normalized to housekeeping genes Pum1, Tbp, and Psmc4 expression. Data are expressed as mean ± SEM. Student's t test; *p ≤ 0.05. DUSP6: dual-specificity phosphatase 6; ERK: extracellular signal-regulated kinase; H&E: hematoxylin and eosin; mRNA: messenger RNA; qPCR: quantitaive polymerase chain reaction by Alcian blue staining which detects acidic mucins (Figure 3c ).
Notably, a thicker inner mucus layer was observed in Dusp6-deficient mouse colon lumen (Figure 3d ), as evidenced by Carnoy's fixation.
This indicates that increased colonic ERK-dependent signaling after
Dusp6 deletion selectively promotes goblet cell expansion and secretory function.
| Dusp6 deletion protects against DSS-induced colitis in mice
We next assessed the susceptibility of Dusp6 +/+ and Dusp6 -/-mice to colonic injury induced by DSS added in drinking water (Cooper et al., 1993) . After 7 days, control mice had lost nearly 20% of their body weight ( Figure 4a ) and exhibited signs of diarrhea and rectal bleeding, resulting in high DAI (Figure 4b ). In contrast, Dusp6 -/-mice treated with DSS exhibited less weight loss (Figure 4a ), a decreased DAI associated with milder diarrhea and bloody stool symptoms ( Figure 4b ) and decreased histological alterations at the microscopic level ( Figure 4c ). These findings demonstrate that Dusp6 inhibition protects the colon from DSS-induced acute injury. (Moser, Pitot, & Dove, 1990; Su et al., 1992) . As shown in ↕Mucus layer. Scale bars=100 µm. Data are expressed as mean ± SEM. Student's t test; *p ≤ 0.05. DUSP6: dual-specificity phosphatase 6; mRNA: messenger RNA; qPCR: quantitaive polymerase chain reaction BEAUDRY ET AL.
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ERK MAPK pathway in the control of epithelial proliferation in both the small and large intestines (Aliaga et al., 1999; Feng et al., 2011; Haigis et al., 2008; Paquin et al., 2013; Rivard et al., 1999; Voisin et al., 2008) . Notably, phosphorylated and activated forms of ERK1/2 have been mostly found in undifferentiated proliferative crypt cells in human intestine (Aliaga et al., 1999) ERK signaling has been previously shown to negatively regulate enterocyte and enteroendocrine cell differentiation in the intestine (Basak et al., 2017; Ding et al., 2001; Lemieux et al., 2011) . However, Disease activity index of Dusp6 knockout mice and control littermates was calculated by scoring stool softness, occult fecal blood, rectal bleeding, and colon rigidity at sacrifice (n ≥ 21). (c) Hematoxylin and eosin staining was performed on Dusp6 +/+ and Dusp6 −/− colon tissue to score the damage according to the extent of destruction of normal mucosal architecture (0, normal; 1, 2, and 3, respectively, mild, moderate, and extensive damage), presence and degree of cellular infiltration (0, normal; 1, 2, and 3, mild, moderate, and transmural infiltration, respectively), extent of muscle thickening (0, normal; 1, 2, and 3, respectively mild, moderate, and extensive thickening), presence or absence of crypt abscesses (0, absent; 1, present; see arrowheads) and the presence or absence of goblet cell depletion (0, absent; 1, present). (n = 18). Scale bars=250 µm. Data are expressed as mean ± SEM. Student's t test; *p ≤ 0.05, **p ≤ 0.01. DUSP6: dual-specificity phosphatase 6; DSS: dextran sulfate sodium Van Seuningen, 2002; Suzuki, Takeuchi, Ishinaga, Basbaum, & Majima, 2008) . Overall, these observations suggest a role for the Ras/ERK pathway in goblet cell fate and differentiation. However, the exact molecular mechanisms involved remain to be elucidated.
These modulations in crypt cell proliferation and differentiation observed in Dusp6 KO intestine prompted us to determine whether Dusp6 play a role in the intestinal response against injury. We, therefore, investigate a model of ulcerative colitis in the large ; Apc Min/+ polyp histology was visualized with hematoxylin and eosin staining in the small intestine (scale bars: 250 µm) and colon (scale bars: 500 µm; representative of n ≥ 4). (d) Dusp6, PCNA, and phosphorylated ERK1/2 levels were analyzed by western blot of polyp (P) and healthy marge (M) protein extracts (n = 3). ERK1/2 expression was used as loading control. Representative immunoblots are shown. (e) Densitometric analysis of PCNA expression relative to ERK1/2 (n = 7). Data are expressed as mean ± SEM. Student's t test; *p < 0.05, **p < 0.01. DUSP6: dual-specificity phosphatase 6; ERK: extracellular signal-regulated kinase; PCNA: proliferating cell nuclear antigen BEAUDRY ET AL.
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intestine. Treatment of wild-type mice with DSS induces acute colitis.
Interestingly, Dusp6 KO mice exhibited less weight loss, diarrhea, and bloody stools after DSS treatment as well as milder mucosal alterations at the microscopic level. Thus, Dusp6 deficiency in IEC likely protects the colonic mucosae against injury-induced inflammation. Increased IEC proliferation, enhanced goblet cell numbers as well as mucus production may be all implicated in colitis protection.
Indeed, proliferation is important for wound healing after epithelial damage in the intestine and the mucus layer is protective against adhesion and invasion by microbes and antigens (Sturm & Dignass, 2008 By contrast, another study (Bertin et al., 2015) showed that
Dusp6 deletion accelerated and exacerbated inflammation in interleukin-10 deficient (Il10
) mouse model of colitis. The discrepancy between our data and the study of Bertin et al. may be explained by the different experimental models used for colitis induction. Herein, we used DSS which triggers inflammation by causing chemical injury directly to the intestinal epithelium, resulting in exposure of the lamina propria and submucosa to luminal antigens and bacteria (Low, Nguyen, & Mizoguchi, 2013) . Thus, by stimulating goblet cell function as well as crypt proliferation and regeneration, Dusp6 deletion may protect the colonic epithelium against erosion induced by DSS. By contrast, the enterocolitis in Il10 −/− mice is largely attributed to dysfunctional CD4 + T-cell activation (Roers et al., 2004) . In their study, Bertin et al. (2015) clearly demonstrated that Dusp6-deficient occur in approximately 40% and 10%, respectively, of all CRCs (Andreyev, Norman, Clarke, Cunningham, & Oates, 1998; Davies et al., 2002; Rajagopalan et al., 2002; Samowitz et al., 2000) .
Furthermore, several studies have demonstrated that inhibition of MEK/ERK signaling prevents CRC cell growth in cell culture and mouse xenografts (Balmanno et al., 2009; Kress, Raabe, & Feller, 2010; Lemieux et al., 2009; Sebolt-Leopold et al., 1999; Solit et al., 2006; Voisin et al., 2008; Wang et al., 2013 (Maillet et al., 2008) . It is possible that ERK1/2 phosphorylation is induced earlier during the tumorigenic process of Apc
Min/+ mice in the absence of Dusp6. Herein, the mice were killed at 3 months of age to obtain a significant number of polyps (Moser et al., 1990) . To better analyze the regulation of ERK activity during polyposis, it would have been necessary to also sacrifice mice earlier, at the age of 1 or 2 months. That being said, the possibility that Dusp6 dephosphorylates other targets than ERK1/2 cannot be totally excluded. For instance, Dusp6 has been shown to interact with other kinases such as CK2 (Hagan, Knutson, & Lange, 2013) and ERK5 (Razmara, Eger, Rorsman, Heldin, & Lennartsson, 2012; Sarközi et al., 2007) . In this regard, ERK5 is particularly interesting since this | 6741 (Popat, Hubner, & Houlston, 2005 (Davies et al., 2002 ) is a plausible explanation for this discrepancy between these two cell lines. Indeed, there is a correlation between ERK1/2 activation and BRAF, but not KRAS, mutation status in CRC cells and tumors (Yeh et al., 2009 ). In addition, we cannot exclude that HCT116 cells may express higher levels of other DUSP, which in turn can also negatively regulate ERK phosphorylation. For instance, we previously observed higher DUSP4
expression levels in HCT116 cells in comparison to HT29 cells . Regardless of of the reason that explains this difference in ERK phosphorylation modulation between the two cell lines, our results suggest that DUSP6 silencing must result in increased ERK1/2 phosphorylation to stimulate anchorage-independent growth ability and invasion capacity in CRC cells.
A tumor suppressive role for DUSP6 has also been suggested in several cancers (Chan et al., 2008; Furukawa, Sunamura, Motoi, Matsuno, & Horii, 2003; Okudela et al., 2009; Xu, Furukawa, Kanai, Sunamura, & Horii, 2005) . Accordingly, expression levels of DUSP6 are indeed reduced in pancreatic, ovarian and lung cancers (Chan et al., 2008; Furukawa et al., 2003; Okudela et al., 2009; Xu et al., 2005) and DUSP6 overexpression suppresses cancer cell growth (Chan et al., 2008; Furukawa et al., 2003; Okudela et al., 2009) . However, other studies have hinted at an oncogenic function for DUSP6. Indeed, DUSP6 is upregulated in various cancer cell lines including those from glioblastomas, papillary thyroid carcinoma and gastric cancers and its enforced expression in these cancer cell lines clearly increases their growth, migration and/or tumorigenic potential in vivo (Degl'Innocenti et al., 2013; Messina et al., 2011; Wu et al., 2018) . The mechanisms explaining why DUSP6 can act as a tumor suppressor in some cancers and as an oncogene in others still remain to be determined.
In conclusion, our results demonstrate that the DUSP6 phosphatase, by limiting the activation of ERK signaling, regulates colonic inflammatory response and protects the colonic epithelium against oncogenic stress.
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